this findings propose that hepcidin may influence the regulation of tumor growth and metastasis, thereby advocating its potential utility as a biomarker to enhance prognostic assessment and inform therapeutic strategies in breast cancer patients. The gene discussed is HAMP; the disease is breast carcinoma.